Entity Details

Primary name ANOS1
Entity type gene
Source Source Link

Details

PrimaryID3730
RefseqGeneNG_007088
SymbolANOS1
Nameanosmin 1
ChromosomeX
LocationXp22.31
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1994-01-05
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsKALM_HUMAN

GO terms

Show/Hide Table
GOName
GO:0004867 serine-type endopeptidase inhibitor activity
GO:0005201 extracellular matrix structural constituent
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005886 plasma membrane
GO:0006935 chemotaxis
GO:0007155 cell adhesion
GO:0007411 axon guidance
GO:0008201 heparin binding
GO:0008543 fibroblast growth factor receptor signaling pathway
GO:0009986 cell surface
GO:0030182 neuron differentiation
GO:0031012 extracellular matrix

Diseases

Show/Hide Table
Disease IDSourceNameDescription
308700 OMIMHypogonadotropic hypogonadism 1 with or without anosmia (HH1)A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. In some cases, it is associated with non-reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). The disease is caused by variants affecting distinct genetic loci, including the gene represented in this entry. The genetics of hypogonadotropic hypogonadism involves various modes of transmission. Oligogenic inheritance has been reported in some patients carrying mutations in ANOS1 as well as in other HH-associated genes including FGFR1 and TACR3 (PubMed:23643382).

Interactions

12 interactions